7.36
                                            前日終値:
              $8.16
            開ける:
              $6.45
            24時間の取引高:
                300.16K
            Relative Volume:
              2.58
            時価総額:
                $86.75M
            収益:
              $52.29M
            当期純損益:
              $-73.52M
            株価収益率:
              -11.15
            EPS:
                -0.66
            ネットキャッシュフロー:
                $-100.45M
            1週間 パフォーマンス:
              +2.51%
            1か月 パフォーマンス:
              +35.29%
            6か月 パフォーマンス:
                +28.00%
            1年 パフォーマンス:
              -18.40%
            Precision Biosciences Inc Stock (DTIL) Company Profile
名前
                  
                      Precision Biosciences Inc
                    
                セクター
                  電話
                  
                      919-314-5512
                    
                住所
                  
                      302 EAST PETTIGREW STREET, DURHAM, NC
                    
                DTIL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                DTIL
                            
                             
                        Precision Biosciences Inc 
                           | 
                    7.36 | 96.18M | 52.29M | -73.52M | -100.45M | -0.66 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 | 
|---|---|---|---|
| 2025-01-10 | アップグレード | BMO Capital Markets | Market Perform → Outperform | 
| 2024-04-30 | 開始されました | Guggenheim | Buy | 
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform | 
| 2022-06-09 | ダウングレード | William Blair | Outperform → Mkt Perform | 
| 2020-07-27 | 再開されました | BTIG Research | Buy | 
| 2020-04-03 | ダウングレード | Goldman | Buy → Neutral | 
| 2020-03-05 | 開始されました | Stifel | Buy | 
| 2020-02-25 | 開始されました | William Blair | Outperform | 
| 2019-08-09 | 開始されました | BTIG Research | Buy | 
| 2019-07-16 | 開始されました | H.C. Wainwright | Buy | 
| 2019-04-22 | 開始されました | Barclays | Overweight | 
| 2019-04-22 | 開始されました | Goldman | Buy | 
| 2019-04-22 | 開始されました | JP Morgan | Overweight | 
| 2019-04-22 | 開始されました | Jefferies | Buy | 
                    すべてを表示
                    
                  
                Precision Biosciences Inc (DTIL) 最新ニュース
Precision BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Precision BioSciences: Q3 Earnings Snapshot - CTPost
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Multi asset correlation models including Precision BioSciences Inc.Earnings Performance Report & Technical Pattern Alert System - newser.com
Is Precision BioSciences Inc. stock a defensive play in 20252025 Support & Resistance & High Yield Stock Recommendations - newser.com
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - TradingView
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
How Precision BioSciences Inc. stock trades during market volatilityQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Has Precision BioSciences Inc. found a price floorJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Breakouts & Free Verified High Yield Trade Plans - newser.com
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - TipRanks
Can Precision BioSciences Inc. stock resist market sell offsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryDollar Strength & Entry and Exit Point Strategies - newser.com
Imugene to Issue 19.5 Million Shares, Pay $3 Million in Cash to Precision Biosciences as Milestone Payment Under Licensing Agreement - MarketScreener
Will Precision BioSciences Inc. outperform the marketTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidate2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Imugene to explore discussions with FDA, triggering Precision BioSciences milestone - Proactive financial news
Real time breakdown of Precision BioSciences Inc. stock performanceMarket Performance Report & Reliable Breakout Forecasts - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance
A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st
Is Precision BioSciences Inc. stock positioned well for digital economyQuarterly Profit Summary & Verified Entry Point Signals - newser.com
Earnings visualization tools for Precision BioSciences Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Update & AI Driven Stock Reports - newser.com
Precision BioSciences, Inc. (DTIL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Precision Biosciences Inc (DTIL) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):